About PCITEM
The Partnership Contribution Independent Technical Expert Mechanism (PCITEM), comprising 8 experts from a variety of relevant disciplines, will meet each biennium to review the projects submitted for Partnership Contribution (PC) funds use. PCITEM will review and provide scientific and technical guidance and advice to support, improve and finalize the PC funded work plans.
List of experts
Dr Eduardo Azziz-Baumgartner
Chief, Global Influenza Branch, Influenza Division, United States Centre for Disease Control and Prevention
Dr Elena Gavrilova
WHO Collaborating Centre for Studies on Influenza at the Animal-Human Interface, State Research Center of Virology and Biotechnology "VECTOR", Russian Federation
Professor Chung Keel Lee
Former Special Advisor, Ministry of Food and Drug Safety, Republic of Korea
Dr Annick Mondjo
Director of the Infectious Disease Control Program, Ministère de la Santé et des Affaires Sociales, Libreville, Gabon
Dr Mahbubur Rahman
Assistant Professor of Epidemiology with Institute of Epidemiology, Disease Control and Research (IEDCR), Ministry of Health and Family Welfare, Bangladesh
Dr Manal Labib Fahim
Director of General Department of Epidemiology & Surveillance (DES) Preventive Sector, Ministry of Health & Population, Cairo, Egypt
Dr Ian Christian Gonzales
Chief, Public Health Surveillance Division Epidemiology Bureau, Department of Health, Philippines
Meeting reports
Disclaimer
In order to enhance its management of Conflicts of Interest as well as strengthen public trust and transparency in connection with WHO meetings involving the provision of technical/normative advice, the names and brief biographies of individuals (“Published Information” ) being considered for participation in such meetings are disclosed for public notice and comment.
The Published Information is provided by the experts themselves and is the sole responsibility of the individuals concerned. WHO is not responsible for the accuracy, veracity and completeness of the Published Information provided. Furthermore, in no event will WHO be responsible or liable for damages in relation to the use of, and reliance upon, the Published Information.
The comments received by WHO through the public notice and comment process are treated confidentially and their receipt will be acknowledged through a generic email notification to the sender. Comments and perceptions brought to the knowledge of WHO through this process are an integral component of WHO’s conflict of interest assessment policy and are carefully reviewed. WHO reserves the right to discuss information received through this process with the relevant expert with no attribution to the provider of such information. Upon review and assessment of the information received through this process, WHO, in its sole discretion, may take appropriate management action in accordance with its policies.
The participation of an expert in a WHO meeting does not imply that they are endorsed or recommended by the World Health Organization nor does it create a binding relationship between the expert and WHO.
The list of participating experts, a summary of relevant interests disclosed by such experts, and any appropriate mitigation measures taken by WHO relating to the management of conflicts of interests, will be reported publicly in accordance with WHO practice.
To send a comment, please email pipframework@who.int prior to the next meeting.